Atlas Trials

Telotristat Etiprate for Carcinoid Syndrome Therapy

Clinical trial NCT02063659 · COMPLETED

Trial details

NCT number
NCT02063659
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Carcinoid Syndrome
Start date
2014-03-11
Primary completion
2016-03-29
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.